Leidos (NYSE:LDOS) Releases Earnings Results, Beats Estimates By $0.59 EPS

Leidos (NYSE:LDOS) announced its quarterly earnings results on Tuesday. The aerospace company reported $2.29 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.59, RTT News reports. The business had revenue of $3.98 billion during the quarter, compared to analyst estimates of $3.82 billion. Leidos had a net margin of 2.04% and a return on equity of 25.66%. Leidos’s quarterly revenue was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.47 EPS. Leidos updated its FY 2024 guidance to 8.400-8.800 EPS and its FY24 guidance to $8.40-8.80 EPS.

Leidos Stock Up 1.4 %

LDOS stock opened at $142.21 on Thursday. The company has a current ratio of 1.35, a quick ratio of 1.24 and a debt-to-equity ratio of 1.07. The company’s 50 day moving average is $128.44 and its 200 day moving average is $114.73. The stock has a market cap of $19.22 billion, a price-to-earnings ratio of 61.30, a price-to-earnings-growth ratio of 1.75 and a beta of 0.66. Leidos has a 1-year low of $76.58 and a 1-year high of $142.90.

Leidos Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 28th. Investors of record on Tuesday, May 14th will be given a $0.38 dividend. This represents a $1.52 annualized dividend and a dividend yield of 1.07%. The ex-dividend date of this dividend is Friday, June 14th. Leidos’s dividend payout ratio (DPR) is 65.52%.

Analyst Ratings Changes

Several analysts have recently issued reports on LDOS shares. Argus upped their target price on shares of Leidos from $120.00 to $145.00 and gave the stock a “buy” rating in a research note on Wednesday, March 20th. Barclays upgraded shares of Leidos from an “equal weight” rating to an “overweight” rating in a research note on Friday, January 5th. Bank of America upped their target price on shares of Leidos from $125.00 to $145.00 and gave the stock a “buy” rating in a research note on Wednesday, March 27th. TheStreet upgraded shares of Leidos from a “c” rating to a “b” rating in a research note on Tuesday, February 13th. Finally, Jefferies Financial Group upped their target price on shares of Leidos from $130.00 to $135.00 and gave the stock a “hold” rating in a research note on Wednesday, April 10th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, Leidos has a consensus rating of “Moderate Buy” and an average target price of $141.17.

Insider Buying and Selling

In related news, Director David G. Fubini sold 7,874 shares of the company’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $127.89, for a total value of $1,007,005.86. Following the transaction, the director now directly owns 14,696 shares in the company, valued at $1,879,471.44. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, Director Gary Stephen May sold 2,745 shares of the firm’s stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $124.49, for a total value of $341,725.05. Following the transaction, the director now owns 11,352 shares in the company, valued at $1,413,210.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director David G. Fubini sold 7,874 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $127.89, for a total transaction of $1,007,005.86. Following the completion of the transaction, the director now owns 14,696 shares in the company, valued at approximately $1,879,471.44. The disclosure for this sale can be found here. 0.96% of the stock is owned by company insiders.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.